Strontium Ranelate is a medicine used to treat severe osteoporosis.
The product can be sold under the trade name Protelos, it is produced by the Servier laboratory and can be bought in pharmacies in the form of sachets.
Price of Strontium Renelate
The price of Strontium Renelate varies from 125 to 255 reais, depending on the dose of the drug, the laboratory and quantity.
Indications for Strontium Renelate
Strontium Renelate is indicated for postmenopausal women and men at high risk of fracture as it helps reduce the risk of fracture of the vertebrae and the neck of the femur.
This drug has a double action, as it reduces bone resorption and increases the formation of bone mass, making it an alternative for women with menopausal osteoporosis without resorting to hormone replacement.
Mode of Use of Strontium Renelate
Treatment with this medicinal product should only be indicated by a physician experienced in the treatment of osteoporosis.
Generally, it is recommended to take 2 g once daily orally at bedtime for at least 2 hours after a meal.
This medicine should be given at meal intervals since food, especially milk and dairy products, reduces the absorption of strontium renelate.
In addition, patients treated with strontium ranelate should take vitamin D and calcium supplements if diet is inadequate, but only a medical indication.
Contraindications of Strontium Renelate
Strontium renelate is contraindicated in patients with hypersensitivity to the active substance or to the other ingredients of the product formulation.
In addition, it is contraindicated in patients with thrombosis or a history of deep venous thromboembolism and pulmonary embolism and should not be used by pregnant or breastfeeding women.
Secondary Effects of Strontium Renelate
The most common side effects of strontium iron include nausea, diarrhea, headache, insomnia, dizziness and eczema, and pain in the bones and joints.
Strontium Renelate interactions
Strontium Renelate interacts with food, milk, dairy products and antacids, as they reduce the absorption of the drug. In addition, administration should be discontinued during treatment with tetracyclines and quinolones, and use of the drug should only be initiated after the end of treatment with these antibiotics.
